Free v. Abbott Laboratories

953 F. Supp. 751, 1997 U.S. Dist. LEXIS 1574, 1997 WL 63307
CourtDistrict Court, M.D. Louisiana
DecidedJanuary 21, 1997
DocketCivil Action No. 93-971-A
StatusPublished
Cited by1 cases

This text of 953 F. Supp. 751 (Free v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering District Court, M.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Free v. Abbott Laboratories, 953 F. Supp. 751, 1997 U.S. Dist. LEXIS 1574, 1997 WL 63307 (M.D. La. 1997).

Opinion

RULING ON MOTION FOR FINAL APPROVAL OF SETTLEMENTS AND ATTORNEY FEES

JOHN V. PARKER, Chief Judge.

This matter is before the court on a motion by plaintiffs for final approval of settlements entered into with defendants, Abbott Laboratories (“Abbott”) and Bristol-Myers Squibb Company and Mead Johnson & Company (together “Bristol”). Also pending before the court is a joint application of plaintiffs’ counsel for an award of attorneys’ fees and reimbursement of expenses. Neither motion is opposed. Removal jurisdiction is allegedly based upon 28 U.S.C. § 1332 and in a prior ruling the court has held that there is diversity of citizenship jurisdiction in this case.

Motion for Final Approval of Settlement

Background

On October 14, 1993, plaintiffs filed this action seeking damages for economic loss including treble damages, attorney fees, and legal interest. The plaintiffs allege that defendants entered a conspiracy to fix prices in violation of Louisiana’s antitrust law, La.R.S. 51:122 et seq. Specifically plaintiffs allege, “an understanding and concert of action among defendants, the substantial terms of which were to raise, fix, maintain and stabilize at artificially high levels the wholesale price of infant formula sold in the United States, including the state of Louisiana.” The plaintiffs purportedly filed this lawsuit on behalf of themselves and a class of consumers who purchased one or more of the defendants’ brands of infant formula in the state of Louisiana at any time during the period of January 1, 1980 through December 31,1992.

Plaintiffs have now entered settlement agreements with both defendants. The settlements provide that Abbott and Bristol will pay $2,350,000 and $2,000,000 respectively, with accruing interest, to settle the claims asserted against each.1 The settlements, if approved, would conclude this litigation.

[753]*753No class having been certified when the motion was filed, this court tentatively certified a class for settlement purposes only, and preliminarily approved the two settlements. Notices of the settlements were published in newspapers throughout Louisiana as required by Rule 23(e), Fed.R.Civ.P.2 The notice required class members to submit any objection they might have to the settlement administrator regarding the amount of the settlements, attorneys’ fees, expenses, or plaintiffs’ awards on or before December 2, 1996. The court has been informed that the administrator did not receive any objections by mail and that no persons have requested to opt out of the class.

On Monday, December 16, 1996, on a motion by plaintiffs, this court held a fairness hearing concerning final approval of the settlement agreements. Although the notices required prehearing written objections, the court announced that any person in the courtroom would be allowed to comment. No objections or comments were made by any member of the public in the courtroom. Law

A class action shall not be dismissed or compromised without the approval of the court, and notice of the proposed dismissal or compromise shall be given to all members of the class in such manner as the court directs. Fed.R.Civ.P. 23(e). A class action settlement should be approved only when it is “fair, adequate, and reasonable.” In re Corrugated Container Antitrust Litigation, 643 F.2d 195, 207 (5th Cir.1981). In making this determination, a district court should consider the following factors: the possible range of recovery and the certainty of damages; the factual and legal obstacles to prevailing on the merits; the stage of proceedings and the amount of discovery completed; the objections and opinions of absent class members as well as the opinions of class counsel and class representatives; whether the settlement was the product of collusion or fraud; and the complexity, expense, and likely duration of the litigation. Reed v. General Motors Corp., 703 F.2d 170, 172 (5th Cir.1983).

Discussion

To protect the interests of the absentee class, this court has a duty to make an independent assessment of the fairness of the settlement. The court executes this duty by assuring that the settlement secures an adequate advantage for the class in return for the surrender of litigation rights against the defendants. See 2 NewBerg & Conte § 11.46, at 11-105, 11-106. As the Third Circuit has recently pointed out, a district court must be especially careful in reviewing settlements which are presented through the use of a settlement class. In re General Motors Corp. Pick-Up Truck Fuel Tank, 55 F.3d 768, pp. 786-792 (3rd Cir.1995).

To enable the court to reasonably assess the fairness of the settlement, the proponents3 are obligated to furnish adequate information; counsel for the parties are the main source of information concerning the settlement. It is the proponents’ burden to explain how the settlement was reached and to prove that it is fair, adequate, and reasonable. Id.

1) The Possible Range of Recovery and the Certainty of Damages

Proponents failed to furnish significant information about the estimate of the possible range of recovery which class members will surrender in exchange for the settlement. Proponents contend only that the settlement is “unquestionably superior to anr other possibility: that no recovery would be obtained after years of further litigation.” Certainly, this possibility is always present in litigation and is indeed not helpful to the court in evaluating the possible range of recovery.

[754]*754The original state court petition alleges that the value of any claim does not exceed $20,000, but does not reveal the basis for the estimate. The only other information furnished to the court regarding extent of damages is contained in a memorandum on behalf of plaintiffs filed December 13, 1993 in support of their motion to remand. In arguing that the claim of plaintiffs and the purported members of the class fall well below federal jurisdictional amount, counsel declares: “[t]he evidence will establish that a parent purchasing infant foimula has been defrauded out of about $835.35 per year per infant.” Brief of plaintiffs, p. 17.

The brief offers assumptions but no affidavits or other factual information to support the asserted loss figure. Since counsel at that time was attempting to establish that the claims were all' well below the then $50,-000 federal jurisdictional amount, the court must assume that the sum of $835.85 per year per child is the absolute minimum amount that a jury would be asked to award. Taking counsel at their word, the-court concludes that each member of this absentee class will be required to surrender a claim worth at least $2507.55 (antitrust damages are trebled) per child per year under-the terms of the settlement now proposed to the court.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Free v. Abbott Laboratories
982 F. Supp. 1211 (M.D. Louisiana, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
953 F. Supp. 751, 1997 U.S. Dist. LEXIS 1574, 1997 WL 63307, Counsel Stack Legal Research, https://law.counselstack.com/opinion/free-v-abbott-laboratories-lamd-1997.